Article Text

Download PDFPDF
Symptomatic interferon retinopathy successfully treated by hypertension management
  1. C Han1,
  2. J O’Day2
  1. 1
    St Vincent’s Hospital, Fitzroy, Australia
  2. 2
    Department of Neuro-opthalmology, Royal Victorian Eye and Ear Hospital, Melbourne, Australia
  1. Dr C Han, Department of Surgery, St Vincent’s Hospital, 41 Victoria Parade, Fitzroy, Melbourne, Australia 3065; charles.han{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Retinopathy is a common side effect of interferon treatment. We report a case of symptomatic retinopathy caused by interferon α in a hypertensive patient successfully treated by management of hypertension alone and without stopping interferon α. As far as we know, this is the first reported case of interferon retinopathy successfully treated by hypertension management.

Pathogenesis of interferon retinopathy is most likely related to microcirculation damage and the impairment of angiogenesis. If interferon α therapy offers significant clinical benefit but is complicated by retinopathy, by treating other sources of microcirculation injury such as hypertension or diabetes mellitus, symptomatic retinopathy may be successfully treated without ceasing interferon α treatment.

Case report

The patient is a …

View Full Text